SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-148160
Filing Date
2023-05-18
Accepted
2023-05-18 16:18:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d421001ddefa14a.htm DEFA14A 16325
2 GRAPHIC g421001g0518055217562.jpg GRAPHIC 4819
  Complete submission text file 0001193125-23-148160.txt   24109
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Filer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40505 | Film No.: 23936348
SIC: 2836 Biological Products, (No Diagnostic Substances)